Improved alpharetrovirus-based Gag.MS2 particles for efficient and transient delivery of CRISPR-Cas9 into target cells.
Baron Y, Sens J, Lange L, Nassauer L, Klatt D, Hoffmann D, Kleppa MJ, Barbosa PV, Keisker M, Steinberg V, Suerth JD, Vondran FWR, Meyer J, Morgan M, Schambach A, Galla M.
Baron Y, et al. Among authors: steinberg v.
Mol Ther Nucleic Acids. 2022 Jan 1;27:810-823. doi: 10.1016/j.omtn.2021.12.033. eCollection 2022 Mar 8.
Mol Ther Nucleic Acids. 2022.
PMID: 35141043
Free PMC article.